Israel’s Nurami Medical, a company developing next-generation regenerative solutions for soft tissue repair, has announced successful completion of Phase 1 of its EIC-funded grant for Artifix®, a synthetic, biomimetic, dural repair adhesive patch, its second portfolio product.

https://www.prnewswire.com/il/news-releases/nurami-medical-announces-successful-completion-of-phase-1-milestones-in-eic-backed-grant-for-artifix-dural-repair-graft-302610000